GlaxoSmithKline (GSK) and other pharmas concerned by parallel trade have been given encouragement by Europe’s highest court which said the EC must reconsider the company’s Spanish sale conditions.
European facilities owned by Israel’s Teva Pharmaceuticals and French drugmaker Servier are among the firms raided by the EC’s competition unit earlier this week, according to media reports.
New legislation on the good manufacturing practice (GMP) of
pharmaceutical excipients in Europe, which could complicate the
quality control of imports of excipients to the EU and make it
unattractive for some vendors to remain in...
